UNICA IRIS Institutional Research Information System

SIMOLA, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 165.430
NA - Nord America 6.891
AS - Asia 1.044
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 8
AF - Africa 5
OC - Oceania 3
Totale 173.398
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 164.022
US - Stati Uniti d'America 6.853
CN - Cina 739
UA - Ucraina 479
SE - Svezia 379
SG - Singapore 177
DE - Germania 154
GB - Regno Unito 131
FI - Finlandia 121
VN - Vietnam 68
FR - Francia 41
CA - Canada 35
PL - Polonia 28
KR - Corea 19
IN - India 15
BE - Belgio 14
NL - Olanda 14
CH - Svizzera 10
RU - Federazione Russa 10
EU - Europa 8
CZ - Repubblica Ceca 7
BR - Brasile 6
IR - Iran 6
ES - Italia 5
HK - Hong Kong 5
AR - Argentina 4
AT - Austria 4
IE - Irlanda 4
JP - Giappone 4
CO - Colombia 3
MX - Messico 3
NG - Nigeria 3
PE - Perù 3
NZ - Nuova Zelanda 2
PK - Pakistan 2
RO - Romania 2
TH - Thailandia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
CL - Cile 1
CY - Cipro 1
EG - Egitto 1
HR - Croazia 1
IL - Israele 1
LT - Lituania 1
MA - Marocco 1
MT - Malta 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 173.398
Salva come PNG Salva come JPEG
Città #
Cagliari 159.663
Uta 3.931
Fairfield 1.013
Woodbridge 732
Chandler 594
Ashburn 452
Houston 434
Ann Arbor 396
Seattle 366
Wilmington 353
Cambridge 352
Boardman 322
Nyköping 289
Jacksonville 244
Dearborn 192
New York 190
Beijing 122
Nanjing 111
Santa Clara 108
Singapore 104
Shanghai 98
Hangzhou 90
Boston 82
Dong Ket 68
San Diego 50
Helsinki 48
Guangzhou 35
Shenyang 32
Toronto 29
Norwalk 26
Nanchang 25
Redwood City 25
Falls Church 23
Milan 23
Hebei 22
Los Angeles 21
Sassari 20
London 18
Munich 18
Sestu 18
Cracow 17
Mountain View 16
Seoul 15
Tianjin 15
Verona 14
Brussels 12
Jiaxing 12
Orange 12
Padova 12
Rome 12
Zhengzhou 12
Atlanta 11
Changsha 11
Hefei 11
Jinan 11
Ningbo 11
Washington 11
Chicago 10
Auburn Hills 9
Oristano 9
Genova 8
Phoenix 8
Pune 8
San Mateo 8
Wuhan 8
Chengdu 7
Kunming 7
Redmond 6
Augusta 5
Brno 5
Buffalo 5
Utrecht 5
Walnut 5
Fuzhou 4
Grottammare 4
Indiana 4
Lanus 4
Paris 4
Taizhou 4
Tappahannock 4
Clifton 3
Florence 3
Giessen 3
Hong Kong 3
Kilburn 3
Lima 3
Mexico City 3
Millbury 3
Monopoli 3
Port Harcourt 3
Prescot 3
Quartucciu 3
Radzymin 3
Rockville 3
Saint Paul 3
Shaoxing 3
Stony Brook 3
Vienna 3
Villafranca di Verona 3
Warsaw 3
Totale 171.155
Salva come PNG Salva come JPEG
Nome #
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease 4.154
Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: comparison of the effects of different psychoactive drugs and relevance in drug-induced reward 3.520
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease 3.409
Widespread reduction of dopamine cell bodies and terminals in adult rats exposed to a low dose regimen of MDMA during adolescence 3.346
Role of Adenosine in the basal Ganglia 3.263
Strain dependence of adolescent Cannabis influence on heroin reward and mesolimbic dopamine transmission in adult Lewis and Fischer 344 rats 3.249
The novel psychoactive substance methoxetamine induces persistent behavioral abnormalities and neurotoxicity in rats 3.018
Antagonism of Adenosine A1 or A2A Receptors Amplifies the Effects of 3,4-Methylendioxymethamphetamine (MDMA) on Glial Activation in the Mouse Brain: Relevance to Caffeine-MDMA Interactions 2.974
Elevation of striatal urate in experimental models of Parkinson's disease: a compensatory mechanism triggered by dopaminergic nigrostriatal degeneration? 2.911
Dopaminergic neurodegeneration in a rat model of long-term hyperglycemia: preferential degeneration of the nigrostriatal motor pathway 2.867
Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms 2.800
Protective Agents in Parkinson's Disease: Caffeine and Adenosine A2A Receptor Antagonists 2.792
Direct and long-lasting effects elicited by repeated drug administration on 50-kHz ultrasonic vocalizations are regulated differently: Implications for the study of the affective properties of drugs of abuse 2.727
Modulation of rat 50-kHz ultrasonic vocalizations by glucocorticoid signaling: possible relevance to reward and motivation 2.710
Role of adenosine A2A receptors in motor control: relevance to Parkinson’s disease and dyskinesia 2.640
Effect of crowding, temperature and age on glia activation and dopaminergic neurotoxicity induced by MDMA in the mouse brain 2.570
Methylxanthines and drug dependence: interactions and toxicity 2.556
Symptomatic and Neuroprotective Effects of A2A Receptor Antagonists in Parkinson’s Disease 2.537
Amphetamine usage, misuse, and addiction processes: an overview 2.531
Neuronal and peripheral damages induced by synthetic psychoactive substances: an update of recent findings from human and animal studies 2.445
Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility 2.416
Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l-DOPA-induced rotational behavior in a rodent model of Parkinson's disease 2.412
Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease 2.398
Progression and Persistence of Neurotoxicity Induced by MDMA in Dopaminergic Regions of the Mouse Brain and Association with Noradrenergic, GABAergic, and Serotonergic Damage 2.394
Repeated Administration of 3,4-Methylenedioxymethamphetamine (MDMA) Elevates the Levels of Neuronal Nitric Oxide Synthase in the Nigrostriatal System: Possible Relevance to Neurotoxicity 2.387
Influence of dopamine transmission in the medial prefrontal cortex and dorsal striatum on the emission of 50-kHz ultrasonic vocalizations in rats treated with amphetamine: Effects on drug-stimulated and conditioned calls 2.348
Involvement of Glutamate NMDA Receptors in the Acute, Long-Term, and Conditioned Effects of Amphetamine on Rat 50kHz Ultrasonic Vocalizations 2.321
Activation of adenosine A2A receptors suppresses the emission of pro-social and drug-stimulated 50-kHz ultrasonic vocalizations in rats: possible relevance to reward and motivation 2.308
L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies 2.200
MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex 2.160
Gut Microbiota and Metabolome Alterations Associated with Parkinson’s Disease 2.123
Contribution of Caffeine to the Psychostimulant, Neuroinflammatory and Neurotoxic Effects of Amphetamine-Related Drugs 2.088
Emission of categorized 50-kHz ultrasonic vocalizations in rats repeatedly treated with amphetamine or apomorphine: possible relevance to drug-induced modifications in the emotional state 1.998
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug 1.997
Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons 1.995
Preface [ to The Adenosinergic System. A Non-Dopaminergic Target in Parkinson’s Disease] 1.874
Repeated amphetamine administration and long-term effects on 50-kHz ultrasonic vocalizations: possible relevance to the motivational and dopamine-stimulating properties of the drug 1.868
Role of movement in long-term basal ganglia changes: implications for abnormal motor responses 1.862
Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (S)-CE-123 on Mesocorticolimbic Dopamine System 1.846
Ultrasonic vocalizations as a tool in studying emotional states in rodent models of social behavior and brain disease 1.805
Alteration in the progression of dopamine neuron degeneration: May caffeine offer new perspective? 1.773
null 1.722
Unbinding of Translocator Protein 18 kDa (TSPO) Ligands: From in Vitro Residence Time to in Vivo Efficacy via in Silico Simulations 1.716
Dyskinesia in Parkinson's disease: mechanisms and current non-pharmacological interventions 1.684
Pharmacological therapy of Parkinson's disease: current options and new avenues 1.677
Caffeine consumption and changes in the function of dopaminergic transmission: evidence of a hyperdopaminergic state in rats subchronically treated with caffeine 1.677
Gender Differences in Neurodegeneration, Neuroinflammation and Na+-Ca2+ Exchangers in the Female A53T Transgenic Mouse Model of Parkinson’s Disease 1.675
null 1.651
null 1.638
Repertoire and Biological Function of Ultrasonic Vocalizations in Adolescent and Adult Rats 1.628
Effect of long-term administration of antiretroviral drugs (Tenofovir and Nevirapine) on neuroinflammation and neuroplasticity in mouse hippocampi 1.592
Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat 1.543
Effects of Psychostimulants on Rat Emotional States and Emission of Ultrasonic Vocalizations 1.445
The sweet road to Parkinson's disease 1.442
Ultrasonic vocalizations in rats: a tool for the investigation of psychoactive drugs and neuropsychiatric conditions 1.398
Adenosine A2A receptors: localization and function 1.378
Gender specific reduction of hypermotility by sub-chronic methylphenidate or atomoxetine in SH rats, an animal model of ADHD 1.352
Diabetes, a Contemporary Risk for Parkinson’s Disease: Epidemiological and Cellular Evidences 1.343
Rat 50-kHz ultrasonic vocalizations as a tool in studying neurochemical mechanisms that regulate positive emotional states 1.327
Adenosine signaling in the basal ganglia 1.224
null 1.194
Blockade of globus pallidus adenosine A2A receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D1 or D2 dopamine receptor agonists 1.190
Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats 1.189
Rat ultrasonic vocalizations and behavioral neuropharmacology: from the screening of drugs to the study of disease 1.167
Acute perinatal asphyxia impairs non-spatial memory and alters motor coordination in adult male rats 1.112
The 6-hydroxydopamine model of Parkinson's disease 1.111
null 1.108
Anti-HIV drugs promote β-amyloid deposition and impair learning and memory in BALB/c mice 1.075
Adenosine A2A receptor antagonist treatment of Parkinson’s disease 1.073
Adenosine A2A receptor antagonists and Parkinson’s disease: state of the art and future directions 1.055
Neurochemical and Behavioral Characterization after Acute and Repeated Exposure to Novel Synthetic Cannabinoid Agonist 5-MDMB-PICA 1.041
A2A receptor antagonism and dyskinesia in Parkinson’s Disease 1.018
null 1.012
Caffeine Consumption and Changes in the Function of Dopaminergic Transmission: Evidence of a Hyperdopaminergic State in Rats Subchronically Treated with Caffeine 969
null 967
In utero exposure to dexamethasone causes a persistent and age-dependent exacerbation of the neurotoxic effects and glia activation induced by MDMA in dopaminergic brain regions of C57BL/6J mice 961
Methylxanthines and Drug Dependence: A Focus on Interactions with Substances of Abuse 943
Anxyiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: Stimulation of in vitro neurosteroid production affecting GABAA receptor activity 939
Perinatal asphyxia: CNS development and deficits with delayed onset 900
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 873
Perinatal asphyxia: current status and approaches towards neuroprotective strategies, with focus on sentinel proteins 825
Lack of drug- and cue-stimulated emissions of ultrasonic vocalizations in C57BL/6 J mice repeatedly treated with amphetamine 825
Activation of Antioxidant and Proteolytic Pathways in the Nigrostriatal Dopaminergic System After 3,4-Methylenedioxymethamphetamine Administration: Sex-Related Differences 817
Priming of rotational behavior by a dopamine receptor agonist in hemiparkinsonian rats: Movement-dependent induction 811
What do you see as the main priorities, Opportunities, and Challenges in Caffeine Research in the Next Five Years? 805
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex 798
Protective Agents in Parkinson’s Disease: Caffeine and Adenosine A2A Receptor Antagonists 778
Effects of combination antiretroviral drugs (cART) on hippocampal neuroplasticity in female mice 747
Association between novel object recognition/spontaneous alternation behavior and emission of ultrasonic vocalizations in rats: Possible relevance to the study of memory 699
Caffeine 692
Acute and long-term effects elicited by psychoactive drugs on 50-kHz ultrasonic vocalizations in rats: development of a new experimental tool for the study of drug-mediated reward. 692
null 685
Nicotinamide prevents the long-term effects of perinatal asphyxia on apoptosis, non-spatial working memory and anxiety in rats 680
Can dietary substances protect against Parkinson's disease? The case of caffeine 649
Editorial of special issue – Synthetic psychoactive substances and neurological diseases: Toxic and therapeutic effects 610
null 594
Increase of dopamine D2(High) receptors in the striatum of rats sensitized to caffeine motor effects 544
Dopaminergic Treatments for Parkinson’s Disease: Light and Shadows 518
Anxiolytic-like effects of N,N-dialkyl-2-phenylindol-3-ylglyoxylamides by modulation of translocator protein promoting neurosteroid biosynthesis 505
null 504
Totale 167.379
Salva come PNG Salva come JPEG
Categoria #
all - tutte 208.212
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 208.212
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202028.300 0 0 0 0 11.972 7.944 4.429 899 722 804 551 979
2020/202142.452 1.436 1.572 1.972 12.345 8.489 4.244 3.199 2.128 1.064 2.491 1.964 1.548
2021/202210.467 1.147 719 656 770 740 687 720 604 759 1.075 1.110 1.480
2022/202317.432 1.649 2.449 1.978 1.467 1.488 1.707 837 1.260 1.134 1.264 1.513 686
2023/202415.716 713 740 548 865 1.643 2.554 2.484 1.094 709 1.113 1.602 1.651
2024/202517.978 4.557 4.795 4.002 3.286 1.338 0 0 0 0 0 0 0
Totale 174.090